Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.

Li Q, Chen J, Li X, Cui B, Fan Y, Geng N, Chen Q, Zhang P, Feng Y.

Oncol Lett. 2018 Apr;15(4):4517-4522. doi: 10.3892/ol.2018.7898. Epub 2018 Jan 29.

2.

Chaperone-mediated autophagy substrate proteins in cancer.

Tang Y, Wang XW, Liu ZH, Sun YM, Tang YX, Zhou DH.

Oncotarget. 2017 May 3;8(31):51970-51985. doi: 10.18632/oncotarget.17583. eCollection 2017 Aug 1. Review.

3.

Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines.

Januchowski R, Sterzyńska K, Zawierucha P, Ruciński M, Świerczewska M, Partyka M, Bednarek-Rajewska K, Brązert M, Nowicki M, Zabel M, Klejewski A.

Oncotarget. 2017 Jul 25;8(30):49944-49958. doi: 10.18632/oncotarget.18278.

4.

Comparison of Two Apheresis Systems of COBE and Optia for Autologous Peripheral Blood Stem Cell Collection.

Lee SN, Sohn JY, Kong JH, Eom HS, Lee H, Kong SY.

Ann Lab Med. 2017 Jul;37(4):327-330. doi: 10.3343/alm.2017.37.4.327.

5.

Involvement of AF1q/MLLT11 in the progression of ovarian cancer.

Tiberio P, Lozneanu L, Angeloni V, Cavadini E, Pinciroli P, Callari M, Carcangiu ML, Lorusso D, Raspagliesi F, Pala V, Daidone MG, Appierto V.

Oncotarget. 2017 Apr 4;8(14):23246-23264. doi: 10.18632/oncotarget.15574.

6.

MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy.

Meng Y, Gao R, Ma J, Zhao J, Xu E, Wang C, Zhou X.

Sci Rep. 2017 Mar 24;7(1):416. doi: 10.1038/s41598-017-00405-3.

7.

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

Park J, Kim S, Joh J, Remick SC, Miller DM, Yan J, Kanaan Z, Chao JH, Krem MM, Basu SK, Hagiwara S, Kenner L, Moriggl R, Bunting KD, Tse W.

Oncotarget. 2016 Jul 12;7(28):43960-43973. doi: 10.18632/oncotarget.9759.

8.

RE1 silencing transcription factor (REST) negatively regulates ALL1-fused from chromosome 1q (AF1q) gene transcription.

Hu Y, Sun Q, Zhang C, Sha Q, Sun X.

BMC Mol Biol. 2015 Sep 5;16:15. doi: 10.1186/s12867-015-0043-7.

9.

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.

Park J, Schlederer M, Schreiber M, Ice R, Merkel O, Bilban M, Hofbauer S, Kim S, Addison J, Zou J, Ji C, Bunting ST, Wang Z, Shoham M, Huang G, Bago-Horvath Z, Gibson LF, Rojanasakul Y, Remick S, Ivanov A, Pugacheva E, Bunting KD, Moriggl R, Kenner L, Tse W.

Oncotarget. 2015 Aug 21;6(24):20697-710.

10.

Evolution of high mobility group nucleosome-binding proteins and its implications for vertebrate chromatin specialization.

González-Romero R, Eirín-López JM, Ausió J.

Mol Biol Evol. 2015 Jan;32(1):121-31. doi: 10.1093/molbev/msu280. Epub 2014 Oct 3.

11.

HMGN2, a new anti-tumor effector molecule of CD8⁺ T cells.

Su L, Hu A, Luo Y, Zhou W, Zhang P, Feng Y.

Mol Cancer. 2014 Jul 25;13:178. doi: 10.1186/1476-4598-13-178.

12.

HMGB1 in health and disease.

Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D.

Mol Aspects Med. 2014 Dec;40:1-116. doi: 10.1016/j.mam.2014.05.001. Epub 2014 Jul 8. Review.

13.

Expanding the genetic basis of copy number variation in familial breast cancer.

Masson AL, Talseth-Palmer BA, Evans TJ, Grice DM, Hannan GN, Scott RJ.

Hered Cancer Clin Pract. 2014 May 24;12(1):15. doi: 10.1186/1897-4287-12-15. eCollection 2014.

14.

Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes.

Hayashi Y, Suemitsu E, Kajimoto K, Sato Y, Akhter A, Sakurai Y, Hatakeyama H, Hyodo M, Kaji N, Baba Y, Harashima H.

Mol Ther Nucleic Acids. 2014 Mar 18;3:e154. doi: 10.1038/mtna.2014.4.

15.

Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma.

Hu A, Dong X, Liu X, Zhang P, Zhang Y, Su N, Chen Q, Feng Y.

Oncol Lett. 2014 Jan;7(1):115-120. Epub 2013 Nov 7.

16.

Annexin A7 suppresses lymph node metastasis of hepatocarcinoma cells in a mouse model.

Jin Y, Wang S, Chen W, Zhang J, Wang B, Guan H, Tang J.

BMC Cancer. 2013 Nov 4;13:522. doi: 10.1186/1471-2407-13-522.

17.

Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics.

Gamwell LF, Gambaro K, Merziotis M, Crane C, Arcand SL, Bourada V, Davis C, Squire JA, Huntsman DG, Tonin PN, Vanderhyden BC.

Orphanet J Rare Dis. 2013 Feb 21;8:33. doi: 10.1186/1750-1172-8-33.

18.

AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells.

Tiberio P, Cavadini E, Callari M, Daidone MG, Appierto V.

PLoS One. 2012;7(6):e39968. doi: 10.1371/journal.pone.0039968. Epub 2012 Jun 26.

19.

Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo.

Ji SQ, Yao L, Zhang XY, Li XS, Zhou LQ.

J Exp Clin Cancer Res. 2012 Mar 15;31:22. doi: 10.1186/1756-9966-31-22.

20.

Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression.

Sillars-Hardebol AH, Carvalho B, de Wit M, Postma C, Delis-van Diemen PM, Mongera S, Ylstra B, van de Wiel MA, Meijer GA, Fijneman RJ.

Tumour Biol. 2010 Apr;31(2):89-96. doi: 10.1007/s13277-009-0012-1. Epub 2010 Jan 21.

Supplemental Content

Support Center